Interazioni tra farmaci
Rozanolixizumab + Upadacitinib
Gravità: Maggiore
Rozanolixizumab and Upadacitinib: major interaction.
Ultimo aggiornamento
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
Sintesi
Upadacitinib is a JAK inhibitor that suppresses immune signaling, while rozanolixizumab lowers circulating IgG by blocking the neonatal Fc receptor. Used together, the reduced IgG and impaired cellular immunity may raise the risk of serious infections.
Cosa significa questa interazione in parole semplici
Rozanolixizumab and Upadacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Rozanolixizumab belongs to Miscellaneous; Upadacitinib belongs to Musculoskeletal.
Perché avviene
Additive immunosuppression through JAK inhibition and FcRn-mediated IgG reduction.
Cosa fare
Avoid combining where possible; if both are necessary, screen for active infection beforehand and monitor closely for signs of infection. Interrupt therapy if a serious infection develops.
Cosa chiedere al farmacista
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Rozanolixizumab e Upadacitinib, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altre interazioni di Upadacitinib
- Abrocitinib + Upadacitinib Controindicata
- Adenovirus types 4 and 7 live + Upadacitinib Controindicata
- Baricitinib + Upadacitinib Controindicata
- Bcg vaccine live + Upadacitinib Controindicata
- Cyclosporine + Upadacitinib Controindicata
- Dengue vaccine + Upadacitinib Controindicata
Altre interazioni di Rozanolixizumab
- Abatacept + Rozanolixizumab Moderata
- Adalimumab + Rozanolixizumab Moderata
- Ado-trastuzumab + Rozanolixizumab Moderata
- Basiliximab + Rozanolixizumab Moderata
- Bevacizumab + Rozanolixizumab Moderata
- Denosumab + Rozanolixizumab Moderata
Domande frequenti
Can I take Rozanolixizumab with Upadacitinib?
MediHelp rates the interaction as major. Rozanolixizumab and Upadacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Upadacitinib is a JAK inhibitor that suppresses immune signaling, while rozanolixizumab lowers circulating IgG by blocking the neonatal Fc receptor. Used together, the reduced IgG and impaired cellular immunity may raise the risk of serious infections.
How serious is the interaction between Rozanolixizumab and Upadacitinib?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where possible; if both are necessary, screen for active infection beforehand and monitor closely for signs of infection. Interrupt therapy if a serious infection develops.
What other medicines interact with Upadacitinib?
MediHelp also lists interactions of Upadacitinib with, for example, Abrocitinib, Adenovirus types 4 and 7 live, Baricitinib. The full list is on the Upadacitinib page.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
